ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.
ARCH has raised ten venture
funds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.
Industries: Biotechnology
Health Care
Medical
Therapeutics
Pharmaceutical
Life Science
Biopharma
Apps
Mobile Apps
Product Management
Outpatient Care
Genetics
Location: Chicago, Illinois, United States
